Aarey Drugs (AAREYDRUGS) | Stock Overview & Key Data
Aarey Drugs Performance Comparison
Stock Range
Today's Range
Low: ₹64.15
High: ₹66.84
on August 11, 2025
52 Week Range
Low: ₹32.85
High: ₹74.80
on March 28, 2025
on September 5, 2024
All-Time High: ₹74.80 on September 2, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR1.9B
EPS
1.43
P/E Ratio (TTM)
46.74
Forward P/E
N/A
P/B Ratio
11.34
PEG Ratio
-2.10
Div. Yield
N/A
ROE
2.97%
Beta
0.532
Debt to Equity
25.17
Financial Highlights
Profitability
Gross Margin
-1.00%
Operating Margin
-3.18%
Profit Margin
0.85%
Returns and Earnings
Return on Assets (TTM)
0.07%
Return on Equity (TTM)
2.97%
EBITDA
INR120.6M
Net Income (TTM)
INR40.2M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR169.54
Quarterly Revenue Growth (YoY)
-48.60%
Quarterly Earnings Growth (YoY)
-78.20%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Aarey Drugs AAREYDRUGS | 1.90B Small-cap | -0.16% | -3.90% | 26.04% | 36.49% | 16.20% | 25.31% | 81.88% | 54.19% |
| Sun Pharmaceutical SUNPHARMA | 3.84T Large-cap | -2.63% | -5.12% | -10.20% | -8.38% | -16.03% | -8.55% | 73.73% | 198.65% |
| Divi's Laboratories DIVISLAB | 1.57T Large-cap | -7.03% | -14.75% | -0.77% | -0.41% | -2.61% | 22.45% | 58.73% | 91.42% |
| Sun Pharma Advanced SPARC | 46.34B Small-cap | -4.83% | -8.86% | 0.02% | -8.70% | -28.94% | -34.79% | -34.46% | -20.13% |
| Aarti Drugs AARTIDRUGS | 44.59B Small-cap | 0.47% | 3.52% | 17.71% | 21.40% | 7.96% | -4.53% | 14.72% | -7.02% |
| Sequent Scientific SEQUENT | 42.04B Small-cap | -0.34% | -9.41% | 8.30% | 7.32% | -9.00% | 22.29% | 57.12% | 26.68% |
Ownership & Short Interest
Insider Ownership
53.25%
Institutional Ownership
2.34%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
33K
Average 90-Day Volume
52K
Aarey Drugs Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Aarey Drugs would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is AAREYDRUGS's 52-week high and low?
- In the last 52 weeks, Aarey Drugs reached a high of ₹74.80 (on September 5, 2024) and a low of ₹32.85 (on March 28, 2025).
- What is the market cap and P/E ratio for AAREYDRUGS?
- Curious about Aarey Drugs's size and valuation? Its market capitalization stands at 1.90B. When it comes to valuation, the P/E ratio (trailing twelve months) is 46.74, and the forward P/E (looking ahead) is N/A.
- Does AAREYDRUGS pay dividends? If so, what's the yield?
- As for dividends, Aarey Drugs isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Aarey Drugs's main competitors or similar companies to consider before investing?
When looking at Aarey Drugs, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.84T Healthcare Drug Manufacturers - Specialty & Generic -8.55% 73.73% Divi's Laboratories
DIVISLAB1.57T Healthcare Drug Manufacturers - Specialty & Generic 22.45% 58.73% Sun Pharma Advanced
SPARC46.34B Healthcare Drug Manufacturers - Specialty & Generic -34.79% -34.46% Aarti Drugs
AARTIDRUGS44.59B Healthcare Drug Manufacturers - Specialty & Generic -4.53% 14.72% Sequent Scientific
SEQUENT42.04B Healthcare Drug Manufacturers - Specialty & Generic 22.29% 57.12% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Aarey Drugs & Pharmaceuticals Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Aarey Drugs's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 2.97%, the Debt to Equity ratio from the most recent quarter is 25.17, and its Gross Profit Margin stands at -1.00%.
- What is the recent revenue and earnings growth for AAREYDRUGS?
- Looking at Aarey Drugs's growth, its revenue over the trailing twelve months (TTM) was INR5B. Compared to the same quarter last year (YoY), quarterly revenue grew by -48.60%, and quarterly earnings saw a YoY growth of -78.20%.
- How much of AAREYDRUGS stock is held by insiders and institutions?
- Wondering who owns Aarey Drugs stock? Company insiders (like executives and directors) hold about 53.25% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 2.34%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.